More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2025-12-19-12-52-09-069-69454a795f578b1a57f25bb9.jpg)

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2025-12-10-07-32-05-080-693921f5c47d027aed97f070.jpg)